Losartan, a nonpeptide angiotensin II type 1 receptor blocker, has led to several instances of a severe hepatocellular injury.1157 A biopsy in one case showed severe chronic hepatitis. Candesartan caused reversible bile stasis, portal cholangitis and ductopenia in a patient presenting with abdominal...